Sun Pharma has no immediate plans to enter into vaccine production as getting into the vertical would require an altogether different manufacturing set-up, as per a top company official. The Mumbai-based company, which is strong in various generic therapeutic segments, is eyeing biosimilars to fuel its future growth. The billionaire industrialist noted that for getting into vaccine production, a completely new set of manufacturing infrastructure is required. So, we currently don't have any facility which we are looking at for producing vaccines," Shanghvi said. On business outlook, Shanghvi noted: “Given the uncertainties of the pandemic in the near term, we are refraining from giving guidance for FY22.

Source: Mint June 13, 2021 07:51 UTC